Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Liquidambar Styraciflua Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of Sweetgum tree pollen allergies via skin testing and immunotherapy.
Name
Liquidambar Styraciflua Pollen
Raw Name
LIQUIDAMBAR STYRACIFLUA POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
26
Variant Count
28
Last Verified
February 17, 2026
About Liquidambar Styraciflua Pollen
Liquidambar Styraciflua Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of Sweetgum tree pollen allergies via skin testing and immunotherapy.
Detailed information about Liquidambar Styraciflua Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Liquidambar Styraciflua Pollen.
Liquidambar Styraciflua Pollen, commonly known as American Sweetgum pollen, is a biological substance used in the field of allergy and immunology. It belongs to a class of drugs known as non-standardized pollen allergenic extracts. These extracts are derived from the pollen of the Liquidambar styraciflua tree, a deciduous tree native to the southeastern United States and parts of Mexico and Central America. In clinical practice, this extract is utilized for two primary purposes: the diagnosis of Type I hypersensitivity (allergic) reactions through skin testing and the long-term treatment of these allergies through a process known as allergen immunotherapy (hyposensitization).
As a 'non-standardized' extract, Liquidambar Styraciflua Pollen is prepared by extracting the allergenic proteins from the raw pollen using a solvent, typically a buffered saline or glycerinated solution. Unlike 'standardized' extracts (such as those for certain grasses or dust mites), non-standardized extracts do not have a federally mandated potency test that correlates with a specific biological response in humans. Instead, their strength is usually expressed in terms of weight/volume (w/v) ratio or Protein Nitrogen Units (PNU) per milliliter. The FDA has permitted the use of these extracts based on historical clinical use and their role in the management of seasonal allergic rhinitis (hay fever) and allergic asthma.
To understand how this extract works, one must first understand the pathophysiology of a pollen allergy. In a sensitized individual, the immune system incorrectly identifies the proteins within the Sweetgum pollen as harmful invaders. The body produces Immunoglobulin E (IgE) antibodies specific to these pollen proteins. These IgE antibodies bind to the surface of mast cells (found in tissues) and basophils (found in the blood). When the patient is later exposed to Sweetgum pollen, the pollen proteins cross-link the IgE on these cells, triggering the release of inflammatory mediators such as histamine, leukotrienes, and cytokines. This results in the classic symptoms of sneezing, itching, runny nose, and watery eyes.
When used for diagnostic purposes, a tiny amount of the Liquidambar Styraciflua Pollen extract is introduced into the skin (via prick or intradermal testing). If the patient is sensitized, a localized 'wheal-and-flare' reaction occurs within 15 to 20 minutes, confirming the presence of specific IgE antibodies.
When used for immunotherapy, the extract is administered in gradually increasing doses. The goal is to shift the immune system's response from an 'allergic' profile (Th2-mediated) to a 'tolerant' profile (Th1 and T-regulatory mediated). Over time, this process induces the production of 'blocking antibodies' (IgG4), reduces the sensitivity of mast cells, and increases the activity of regulatory T-cells that suppress the allergic inflammation. This leads to a significant reduction in symptoms upon natural exposure to the tree pollen.
The pharmacokinetics of allergenic extracts like Liquidambar Styraciflua Pollen differ significantly from traditional synthetic drugs. Because these are complex mixtures of proteins, they do not follow standard absorption and distribution curves.
Liquidambar Styraciflua Pollen extract is indicated for the following:
Liquidambar Styraciflua Pollen is available in several liquid formulations, typically supplied in multi-dose vials:
> Important: Only your healthcare provider can determine if Liquidambar Styraciflua Pollen is right for your specific condition. The selection of the specific extract and the concentration must be tailored to your individual sensitivity levels.
Dosage for Liquidambar Styraciflua Pollen is highly individualized and must be determined by an allergist or immunologist based on the patient's clinical history and skin test reactivity.
Immunotherapy consists of two distinct phases:
Liquidambar Styraciflua Pollen is generally considered safe for use in children, typically starting at age 5. The dosing logic is identical to that of adults, based on individual sensitivity rather than body weight. However, younger children may have a harder time communicating symptoms of a systemic reaction, so extra caution is required. Immunotherapy is rarely started in children under the age of 5 due to the difficulty of monitoring for adverse events.
No specific dosage adjustments are required for patients with renal impairment, as the proteins are metabolized proteolytically rather than cleared primarily by the kidneys. However, the patient's overall health and ability to tolerate a systemic reaction must be considered.
No dosage adjustments are defined for hepatic impairment. The metabolism of allergenic proteins does not rely on the cytochrome P450 system.
Caution should be exercised in elderly patients, particularly those with underlying cardiovascular disease. If an elderly patient experiences a systemic reaction, their heart may be less able to handle the stress or the effects of emergency epinephrine.
If a dose is missed during the build-up phase, the next dose may need to be reduced to ensure safety, depending on how much time has passed. If a dose is missed during the maintenance phase, the doctor may either repeat the last dose or reduce it slightly before resuming the schedule. Never 'double up' on doses to catch up.
An overdose in the context of immunotherapy means receiving a dose significantly higher than the patient's current tolerance level. This can lead to a severe systemic reaction or anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. The schedule is designed to keep you safe while desensitizing your immune system.
Most patients undergoing immunotherapy with Liquidambar Styraciflua Pollen will experience some form of local reaction. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Liquidambar Styraciflua Pollen and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' effects of Liquidambar Styraciflua Pollen extract on organs like the liver or kidneys. The primary long-term consideration is the successful modulation of the immune system. In rare cases, patients may develop a persistent sensitivity to the extract components (like glycerin), though this is uncommon. Most long-term effects are positive, involving a permanent or long-lasting reduction in allergy symptoms.
While Liquidambar Styraciflua Pollen may not always carry a specific boxed warning on every single manufacturer's label, the FDA requires a general class warning for all allergenic extracts regarding the risk of Anaphylaxis.
Summary of Warning Content:
Report any unusual symptoms to your healthcare provider. Even a 'large' local reaction should be reported, as it may predict a future systemic reaction.
Liquidambar Styraciflua Pollen extract is a potent biological product. Safety is paramount, and the medication must only be used by specialists. The most critical safety consideration is the prevention and management of anaphylaxis. Patients should be in their baseline state of health when receiving injections; if you are suffering from an acute infection, a fever, or an asthma flare-up, your injection should be postponed.
No FDA black box warnings for Liquidambar Styraciflua Pollen specifically, but it falls under the mandatory class warnings for all allergenic extracts. The warning emphasizes that severe systemic reactions may occur, that the product is not for home use, and that patients must be monitored for 30 minutes post-injection. It also notes that patients with severe, unstable, or steroid-dependent asthma are at increased risk for fatal reactions.
Unlike many drugs, Liquidambar Styraciflua Pollen does not require routine blood work (like liver or kidney function tests). Monitoring is clinical:
Generally, this medication does not cause sedation or cognitive impairment. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive until they are fully recovered and cleared by a physician.
There is no direct chemical interaction between alcohol and Liquidambar Styraciflua Pollen. However, alcohol can cause vasodilation (widening of blood vessels), which may theoretically speed up the absorption of the allergen or mask the early signs of an allergic reaction. It is best to avoid alcohol for several hours before and after an injection.
Immunotherapy can be stopped at any time, but stopping prematurely (before 3 years) often results in the return of allergy symptoms. There is no 'withdrawal syndrome' associated with stopping allergenic extracts, as they are not physically addictive and do not alter neurotransmitter levels.
> Important: Discuss all your medical conditions with your healthcare provider before starting Liquidambar Styraciflua Pollen, especially any history of heart disease or severe asthma.
While there are few absolute 'drug-drug' contraindications in the chemical sense, certain combinations are avoided for safety reasons:
There are no specific food interactions with Liquidambar Styraciflua Pollen. However, patients with 'Oral Allergy Syndrome' (Pollen-Food Allergy Syndrome) might find that their sensitivity to certain fruits or vegetables increases slightly during the peak of the Sweetgum pollen season or during the build-up phase of immunotherapy. This is due to cross-reactivity between pollen proteins and food proteins.
There is little clinical data on interactions with herbal supplements. However, supplements that have 'immune-boosting' claims (like Echinacea or high-dose Zinc) should be discussed with an allergist, as the goal of immunotherapy is immune modulation, and interfering with the immune response could theoretically affect efficacy.
For each major interaction, the management strategy involves either stopping the interfering medication (if safe), choosing an alternative therapy for the underlying condition, or adjusting the immunotherapy protocol to account for the increased risk.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any medications for blood pressure, heart rhythm, or depression.
Liquidambar Styraciflua Pollen should NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by the physician:
Patients allergic to Sweetgum pollen may also show sensitivity to other members of the Altingiaceae or Hamamelidaceae families. While cross-reactivity is not as common as it is among different types of grasses, a patient who is highly sensitive to one tree pollen may have a lower threshold for reactions when multiple extracts are administered simultaneously in a 'cocktail' injection.
> Important: Your healthcare provider will evaluate your complete medical history, including your lung function and cardiovascular health, before prescribing Liquidambar Styraciflua Pollen.
Pregnancy Category: C. There are no adequate and well-controlled studies of Liquidambar Styraciflua Pollen in pregnant women.
It is generally considered safe to continue immunotherapy while breastfeeding. The allergenic proteins are processed locally and are unlikely to be excreted in breast milk in any significant quantity. There are no known adverse effects on the nursing infant.
Immunotherapy with Sweetgum pollen is approved for children, typically those 5 years of age and older. It is particularly effective in children as it may prevent the 'allergic march'—the progression from allergic rhinitis to asthma. Special care must be taken to monitor children for 30 minutes, as they may not always recognize the early signs of a systemic reaction.
In patients over 65, the decision to use Liquidambar Styraciflua Pollen must take into account the higher prevalence of cardiovascular disease and polypharmacy (taking multiple medications). The risk of a systemic reaction is not necessarily higher in the elderly, but the consequences of a reaction are more likely to be severe.
No specific studies have been conducted in patients with renal failure. However, given the nature of the product (proteins), no dose adjustment is expected to be necessary. The patient's overall stability is the most important factor.
No dose adjustment is required for patients with liver disease. The liver is not the primary site of clearance for these allergenic proteins.
> Important: Special populations require individualized medical assessment. Always inform your allergist if you become pregnant or develop new health problems during treatment.
Liquidambar Styraciflua Pollen acts as an immunomodulator. The primary mechanism involves the induction of peripheral T-cell tolerance. During the build-up phase, repeated exposure to the allergen leads to:
The effect of the extract is not immediate. While skin test reactivity may decrease slightly after several months, the full clinical benefit (reduction in hay fever symptoms) usually takes 6 to 12 months of consistent treatment to manifest. The duration of effect can be long-lasting; many patients remain symptom-free for years after completing a 3-to-5-year course of immunotherapy.
| Parameter | Value |
|---|---|
| Bioavailability | Variable (Subcutaneous absorption is slow) |
| Protein Binding | N/A (Proteins interact with cell receptors) |
| Half-life | Hours to Days (for the proteins) |
| Tmax | 1-2 hours (for systemic uptake of minor components) |
| Metabolism | Proteolysis (Breakdown by enzymes) |
| Excretion | Minimal renal excretion of intact proteins |
Liquidambar Styraciflua Pollen extract is a complex biological mixture. It contains various proteins, glycoproteins, and polysaccharides. The most important components are the allergenic proteins, which typically have molecular weights ranging from 10 to 70 kDa. The extract is usually clear to light yellow or amber in color. It is soluble in water and buffered saline.
It is classified as a Non-Standardized Pollen Allergenic Extract. It belongs to the broader category of Immunotherapy agents. Related medications include standardized grass pollen extracts (like Timothy grass) and other tree pollen extracts (like Oak, Birch, or Maple).
Common questions about Liquidambar Styraciflua Pollen
Liquidambar Styraciflua Pollen extract is primarily used for the diagnosis and treatment of allergies related to the American Sweetgum tree. In diagnostic settings, it is used in skin prick tests to confirm if a patient is sensitized to this specific pollen. For treatment, it is used in allergen immunotherapy, commonly known as 'allergy shots.' This process involves giving the patient gradually increasing amounts of the pollen extract to desensitize their immune system. Over time, this reduces the severity of symptoms like sneezing, itchy eyes, and asthma caused by Sweetgum pollen exposure.
The most common side effects are localized reactions at the site of the injection. These include redness, itching, and swelling, which usually appear shortly after the shot is administered. Most of these local reactions are mild and resolve within a few hours. Some patients may also experience a 'large local reaction' where the swelling is several inches wide and lasts for a day or two. While these are uncomfortable, they are generally not dangerous, though you should always report them to your doctor before your next dose.
There is no direct interaction between alcohol and the pollen extract itself. However, healthcare providers generally recommend avoiding alcohol for several hours before and after your allergy shots. Alcohol can cause your blood vessels to dilate, which might theoretically speed up the absorption of the allergen into your bloodstream, increasing the risk of a systemic reaction. Additionally, being under the influence of alcohol can make it harder for you to notice or describe early symptoms of a serious allergic reaction, which is a significant safety concern.
Liquidambar Styraciflua Pollen is classified as Pregnancy Category C. It is generally not recommended to start allergy shots while you are pregnant because of the risk of a severe allergic reaction (anaphylaxis), which could harm the fetus by reducing oxygen supply. However, if you are already on a stable maintenance dose and find out you are pregnant, your allergist may decide it is safe to continue your treatment. You should have a detailed discussion with your specialist to weigh the risks of the treatment against the benefits of controlling your allergy symptoms during pregnancy.
Allergen immunotherapy is a long-term treatment and does not provide immediate relief like an antihistamine would. Most patients begin to notice an improvement in their seasonal allergy symptoms after 6 to 12 months of consistent injections. The full benefits are typically seen during the second or third year of treatment. Because the process involves slowly retraining the immune system, it requires patience and adherence to the injection schedule to be effective.
Yes, you can stop taking the injections suddenly without experiencing physical withdrawal symptoms. Unlike some medications that affect the nervous system, allergenic extracts do not cause dependency. However, if you stop the treatment before completing the recommended 3-to-5-year course, your allergy symptoms are likely to return over time. If you need to stop or pause your treatment due to illness or travel, always consult your allergist first, as they will need to adjust your dose when you restart.
If you miss a scheduled allergy shot, contact your allergist's office as soon as possible to reschedule. Do not attempt to take a higher dose at your next visit. Depending on how much time has passed since your last injection, your doctor may need to repeat your last dose or even reduce the dose slightly to ensure your safety. Missing multiple doses may require you to move back several steps in your build-up schedule to prevent a systemic reaction when you resume.
There is no clinical evidence to suggest that Liquidambar Styraciflua Pollen or other allergenic extracts cause weight gain. These extracts consist of small amounts of natural proteins that do not affect your metabolism, appetite, or fat storage. If you experience weight changes while on immunotherapy, they are likely due to other factors, such as lifestyle changes or other medications you may be taking (like oral steroids for severe asthma), and you should discuss them with your primary care physician.
In most cases, yes, but there are important exceptions. You must tell your doctor if you are taking beta-blockers or ACE inhibitors for blood pressure or heart conditions, as these can make allergic reactions more dangerous and harder to treat. Most other allergy medications, like antihistamines and nasal sprays, can be continued and are often helpful in managing the minor side effects of the shots. Always provide your allergist with a complete list of all prescriptions, over-the-counter drugs, and supplements you use.
The concept of 'generic' vs. 'brand name' is slightly different for allergenic extracts than for pills. Liquidambar Styraciflua Pollen is produced by several different biological laboratories (such as Greer, ALK, or HollisterStier). While the specific manufacturing process may vary slightly between companies, they are all considered 'Liquidambar Styraciflua Pollen Extract.' Your allergist will typically use one consistent supplier for your treatment to ensure the potency remains as stable as possible throughout your therapy.